Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

High-Dose Fluconazole for the Treatment of Cryptococcal Meningitis in HIV-Infected Individuals

Phase 1

Completed

Conditions: Cryptococcal Meningitis
HIV Infections

Interventions: Drug: Fluconazole
Drug: Amphotericin B

First Posted Date: 2009-04-22

Last Posted Date: 2021-11-04

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 168

Registration Number: NCT00885703

Locations: 🇺🇬
Joint Clinical Research Centre (JCRC)/Kampala Clinical Research Site, Kampala, Uganda
🇿🇦
Durban International Clinical Research Site CRS, Durban, KwaZulu-Natal, South Africa
🇺🇸
University of Southern California CRS, Los Angeles, California, United States

and more 7 locations

Safety and Immune Response of a Rotavirus Vaccine in HIV-infected and Uninfected Children Born to HIV-infected Mothers

Phase 2

Completed

Conditions: Rotavirus Infection
HIV Infection

Interventions: Biological: RotaTeq
Biological: Placebo

First Posted Date: 2009-04-14

Last Posted Date: 2021-11-05

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 202

Registration Number: NCT00880698

Locations: 🇿🇼
Harare Family Care CRS, Harare, Zimbabwe
🇹🇿
Kilimanjaro Christian Medical Center CRS, Moshi, Tanzania
🇧🇼
Molepolole CRS, Gaborone, Botswana

and more 3 locations

High Dose IMVAMUNE® in Vaccinia-Naive Individuals

Phase 2

Completed

Conditions: Smallpox

Interventions: Biological: MVA Smallpox Vaccine
Other: Placebo

First Posted Date: 2009-04-10

Last Posted Date: 2025-06-13

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 91

Registration Number: NCT00879762

Locations: 🇺🇸
University of Iowa - Vaccine Research and Education Unit, Iowa City, Iowa, United States
🇺🇸
Saint Louis University Center for Vaccine Development, Saint Louis, Missouri, United States

Etiology, Pathogenesis, and Natural History of Idiopathic CD4+ Lymphocytopenia

Recruiting

Conditions: Cryptococcal Meningitis
Warts
Idiopathic CD4+ Lymphocytopenia

First Posted Date: 2009-03-23

Last Posted Date: 2025-06-10

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 950

Registration Number: NCT00867269

Locations: 🇺🇸
National Institutes of Health Clinical Center, Bethesda, Maryland, United States

Dose Escalation Study of SQ109 in Healthy Adult Volunteers

Phase 1

Completed

Conditions: TB Multi-drug Resistant

Interventions: Drug: SQ109
Drug: Placebo

First Posted Date: 2009-03-20

Last Posted Date: 2011-11-06

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 10

Registration Number: NCT00866190

Locations: 🇺🇸
Quintiles Phase I Services, Overland Park, Kansas, United States

Safety and Effectiveness of HIV-1 DNA Plasmid Vaccine and HIV-1 Recombinant Adenoviral Vector Vaccine in HIV-Uninfected, Circumcised Men and Male-to-Female (MTF) Transgender Persons Who Have Sex With Men

Phase 2

Terminated

Conditions: HIV Infections

Interventions: Biological: DNA vaccine placebo
Biological: DNA plasmid vaccine
Biological: Recombinant adenoviral serotype 5 (rAD5) vector vaccine
Biological: HIV-1 recombinant adenovirus vaccine placebo

First Posted Date: 2009-03-19

Last Posted Date: 2021-10-15

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 2504

Registration Number: NCT00865566

Locations: 🇺🇸
VRC Clinical Trials Core CRS, Bethesda, Maryland, United States
🇺🇸
The AIDS Research Alliance of America CRS, Los Angeles, California, United States
🇺🇸
UCLA CARE Center CRS, Los Angeles, California, United States

and more 19 locations

Estivation of Malaria Vector Mosquitoes in the Sahelian Region of Mali

Completed

Conditions: Malaria

First Posted Date: 2009-03-18

Last Posted Date: 2017-07-02

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Registration Number: NCT00863408

Locations: 🇺🇸
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States

Combination Pain Therapy in HIV Neuropathy

Phase 2

Terminated

Conditions: HIV Infections
Peripheral Neuropathy

Interventions: Drug: Duloxetine
Drug: Duloxetine placebo
Drug: Methadone
Drug: Methadone placebo

First Posted Date: 2009-03-17

Last Posted Date: 2021-11-04

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 15

Registration Number: NCT00863057

Locations: 🇺🇸
Houston AIDS Research Team CRS, Houston, Texas, United States
🇺🇸
Ucsd, Avrc Crs, San Diego, California, United States
🇺🇸
Harbor-UCLA Med. Ctr. CRS, Torrance, California, United States

and more 5 locations

SCOT Scleroderma Treatment Alternative Registry (STAR Registry)

Completed

Conditions: Sclerosis
Scleroderma, Systemic

First Posted Date: 2009-03-12

Last Posted Date: 2017-04-05

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 19

Registration Number: NCT00860548

Locations: 🇺🇸
University of Texas, Houston Medical School, Houston, Texas, United States

VRC 307: A Double-Blind, Randomized Phase I Study of the Safety and Immunogenicity of a Prime-Boost Schedule of the Investigational DNA Trivalent Influenza Vaccine, VRC-FLUDNA047-00-VP, Followed by the 2008/2009 Seasonal Influenza Trivalent Inactivat...

Phase 1

Completed

Conditions: Influenza, Human

First Posted Date: 2009-03-10

Last Posted Date: 2017-07-02

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 51

Registration Number: NCT00858611

Locations: 🇺🇸
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy